ES2014518A6 - Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada. - Google Patents

Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada.

Info

Publication number
ES2014518A6
ES2014518A6 ES8702873A ES8702873A ES2014518A6 ES 2014518 A6 ES2014518 A6 ES 2014518A6 ES 8702873 A ES8702873 A ES 8702873A ES 8702873 A ES8702873 A ES 8702873A ES 2014518 A6 ES2014518 A6 ES 2014518A6
Authority
ES
Spain
Prior art keywords
sustained release
release composition
mixed
active agent
pregelatimized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8702873A
Other languages
English (en)
Inventor
Henry C Gan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2014518A6 publication Critical patent/ES2014518A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE UNA COMPOSICION FARMACEUTICA DE LIBERACION RETARDADA, CARACTERIZADO PORQUE SE MEZCLA UN AGENTE ACTIVO FARMACOLOGICAMENTE CON: A) UNA CELULOSA MICROCRISTALINA, Y B) CON HIDROXIPROPIL-METILCELULOSA, LA RELACION EN PESO ENTRE A) Y B) SIENDO POR LO MENOS DE 1 A 1, CON LA CONDICION DE QUE CUANDO EL AGENTE ACTIVO ES DISTINTO DE ACIDO ACETILSALICILICO, SE MEZCLA TAMBIEN ALMIDON PREGELATIMIZADO.
ES8702873A 1986-10-09 1987-10-08 Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada. Expired - Lifetime ES2014518A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2014518A6 true ES2014518A6 (es) 1990-07-16

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8702873A Expired - Lifetime ES2014518A6 (es) 1986-10-09 1987-10-08 Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada.

Country Status (24)

Country Link
JP (1) JPS63101334A (es)
KR (1) KR880004801A (es)
AU (1) AU7942087A (es)
BE (1) BE1000732A5 (es)
CA (1) CA1332809C (es)
CH (1) CH675831A5 (es)
DE (1) DE3733540A1 (es)
DK (1) DK527487A (es)
ES (1) ES2014518A6 (es)
FI (1) FI874414L (es)
FR (1) FR2604902B1 (es)
GB (2) GB8624213D0 (es)
GR (1) GR871550B (es)
HU (1) HU201875B (es)
IL (1) IL84104A0 (es)
IT (1) IT1221493B (es)
LU (1) LU87009A1 (es)
NL (1) NL8702294A (es)
NO (1) NO874200L (es)
NZ (1) NZ222083A (es)
PH (1) PH24227A (es)
PT (1) PT85880B (es)
SE (1) SE8703889L (es)
ZA (1) ZA877617B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
PL198797B1 (pl) * 1999-03-31 2008-07-31 Janssen Pharmaceutica Nv Zastosowanie wstępnie żelowanej skrobi
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
ES2330227T3 (es) * 2004-09-09 2009-12-07 Psicofarma, S.A. De C.V. Composicion farmaceutica de liberacion prolongada de hidralazina y su uso como apoyo para el tratamiento de cancer.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
FI874414A7 (fi) 1988-04-10
HU201875B (en) 1991-01-28
IT1221493B (it) 1990-07-06
SE8703889L (sv) 1988-04-10
FR2604902B1 (fr) 1991-04-26
HUT52958A (en) 1990-09-28
ZA877617B (en) 1989-05-30
NZ222083A (en) 1991-05-28
NO874200D0 (no) 1987-10-07
KR880004801A (ko) 1988-06-27
GB8624213D0 (en) 1986-11-12
PH24227A (en) 1990-05-04
FI874414A0 (fi) 1987-10-07
GB8723515D0 (en) 1987-11-11
LU87009A1 (fr) 1988-05-03
DK527487A (da) 1988-04-10
CH675831A5 (es) 1990-11-15
AU7942087A (en) 1988-04-14
FI874414L (fi) 1988-04-10
GB2195893A (en) 1988-04-20
IL84104A0 (en) 1988-03-31
FR2604902A1 (fr) 1988-04-15
GB2195893B (en) 1991-05-08
CA1332809C (en) 1994-11-01
DE3733540A1 (de) 1988-04-14
NO874200L (no) 1988-04-11
GR871550B (en) 1988-02-15
NL8702294A (nl) 1988-05-02
IT8748469A0 (it) 1987-10-08
BE1000732A5 (fr) 1989-03-21
PT85880A (en) 1987-11-01
DK527487D0 (da) 1987-10-08
JPS63101334A (ja) 1988-05-06
PT85880B (pt) 1990-07-31
SE8703889D0 (sv) 1987-10-08

Similar Documents

Publication Publication Date Title
ES2042541T4 (es) Un procedimiento de preparacion de una formulacion farmaceutica de liberacion retardada que contiene goma de xantano.
ES2010226A6 (es) Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos
ATE66143T1 (de) Feste zubereitung mit langsamer freisetzung.
ES2128369T3 (es) Procedimiento para la fabricacion de formas farmaceuticas solidas con liberacion prolongada en dos etapas.
FI820467L (fi) Farmaceutiska kompositioner som frigoers kontinuerligt
BG103047A (en) Granulate for the preparation of quick decomposition and quick dissolving compositions having high medicamentous form content
IE873213L (en) Galenical Formulation
ES2019398B3 (es) Nueva composicion para alimentacion de rumiantes, que contiene una sustancia biologicamente activa y su preparacion.
UY23804A1 (es) Procedimiento de preparacion de medicamentos en forma de comprimidos con liberacion retardada de sustancia activa.
ES2026198T3 (es) Compuesto a base de acido valproico solido, estable a la humedad y metodo para su preparacion.
ATE91232T1 (de) Hydroxypropylcelluloseether enthaltende mittel mit verzoegerter wirkstoffabgabe.
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
KR900012606A (ko) 이중 정제
ES2062206T3 (es) Composicion estabilizada de fgf y su produccion.
ES2130638T3 (es) Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
ES2036457B1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
ES2118677T1 (es) Una composicion que comprende un agente activo disuelto en un vehiculo vitrificante y un procedimiento para su preparacion.
MX9307686A (es) Preparacion de liberacion sostenida.
SE8202172L (sv) Topiska farmaceutiska kompositioner
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
EG18379A (en) Novel pharmacological compounds
ES2111547T3 (es) Comprimido de liberacion prolongada.
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
KR880701551A (ko) 제약적 처방
DK0460062T3 (da) Huperzin A-analoger

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001204